CHICAGO, IL, USA I April 03, 2025 I Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago focused on the ...

The trend of prescribing semaglutide to treat cardiovascular disease is expected to continue to grow. At the American College ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...

affordable supply of critical medicines Liraglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist available as an injector pen and used along with diet and exercise to improve ...

Liraglutide injection represents Meitheal’s first commercial injector pen product and its first ... Liraglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...